Ανδρέας Φουστάνος: ''Δεν μπορεί να μπλέκουν το lifestyle με την ιατρική''

Dear Esteemed Participants,The World Conference on Cancer Research and Novel Drug Development (WCCRDD-2026), scheduled for September 14-16, 2026, in Tokyo, Japan. will serve as a premier platform for oncologists, researchers, pharmaceutical experts, and healthcare professionals to explore the latest advancements in cancer treatment and drug discovery. The conference will cover a wide range of topics, including cancer biology, precision medicine, immunotherapy, targeted drug development, and emerging technologies such as AI-driven oncology and nanomedicine. Discussions will also focus on advancements in clinical trials, biomarker discovery, and innovative screening techniques to improve early detection and patient outcomes. Through keynote presentations, panel discussions, workshops, and networking sessions, the summit aims to foster interdisciplinary collaboration and accelerate breakthroughs in cancer therapeutics. By bringing together experts from academia, industry, and healthcare, WCCRDD-2026 will play a crucial role in shaping the future of oncology and revolutionizing cancer treatment strategies worldwide.Welcome To WCCRDD-2026!

Dear Esteemed Guests,It is with great pleasure that we welcome you to the World Conference on Food Innovation and Nutritional Science (WCFINS 2026) taking place from September 14-16, 2026, in Tokyo, Japan. As the world continues to evolve, so do the challenges and opportunities in food science and nutrition. This summit serves as a premier platform for researchers, industry leaders, policymakers, and innovators to come together, share groundbreaking discoveries, and explore sustainable solutions that will shape the future of food and health.Over the next three days, you will have the opportunity to engage in insightful discussions, network with global experts, and discover the latest advancements in food innovation, technology, and nutritional science. Whether through keynote sessions, panel discussions, or interactive workshops, we encourage you to collaborate, exchange ideas, and contribute to shaping a healthier and more sustainable world.We extend our heartfelt gratitude to our distinguished speakers, sponsors, and participants for making this event possible. We look forward to an inspiring and productive summit in the vibrant city of Tokyo!Welcome to WCFINS-2026!

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains one of the deadliest infectious diseases worldwide. Meanwhile, non-tuberculous mycobacteria (NTM) are an increasing global health concern. NTM infections often resemble TB clinically, which can lead to misdiagnosis and inappropriate therapy. Additionally, drug-resistant strains of M. tuberculosis and NTM exacerbate the global antimicrobial resistance crisis. A better understanding of the biology of mycobacterial pathogens and of the mechanisms underlying disease pathogenesis and transmission is critical to reduce their burden worldwide.This EMBO Workshop is the fourth in a successful series held at the Institut Pasteur in Paris, following the meetings organized in 2012, 2016, and 2022. It will bring together scientists, clinicians, public health experts, and representatives from industry and non-profit organizations, who will share recent insights into mycobacterial infections, from fundamental discoveries to translational research, and their practical implications. The program will cover mycobacterial evolution, physiology, metabolism, host–pathogen interactions, immune responses, mechanisms of drug evasion, therapeutic strategies, vaccines, and diagnostics. Emerging experimental models, computational approaches, and artificial intelligence will also be addressed, showing how recent technologies contribute to advancing mycobacterial research and interventions.The goal of this EMBO Workshop is to gather the mycobacteriology community from different regions, sectors, and career stages, fostering discussions across disciplines. This open dialogue will stimulate collaborations and inspire new ideas and strategies to improve the diagnosis, prevention, and treatment of mycobacterial infections. By providing an inclusive environment for sharing knowledge, this EMBO Workshop aims to accelerate research and contribute to practical solutions to strengthen the control of TB and NTM infections worldwide.

The intricate communication between the gut and brain plays a fundamental role in shaping stress resilience and overall health. Emerging research reveals that the gut microbiome, vagal pathways, and neuroimmune interactions not only mediate the body’s response to stress but also contribute to mood regulation, cognitive function, and systemic inflammation. Disruptions in gut-brain signaling have been implicated in stress-related disorders, including anxiety, depression, and metabolic dysfunction, highlighting the need for an integrated understanding of these pathways. This EMBO Workshop convenes leading experts to explore the molecular, neural, immune and microbiome mechanisms underlying gut-brain interactions in stress adaptation. Key topics include the bidirectional influence of gut and brain health, microbiota-derived neuromodulators, choroid plexus in gut-brain communication, neural-immune interaction and autonomic regulation of stress responses. By incorporating insights from basic and clinical research, this EMBO Workshop aims to bridge fundamental discoveries with translational applications, ultimately identifying novel strategies to enhance resilience, mitigate stress-induced disorders, and improve overall health outcomes.